Efficacy and safety of infliximab or adalimumab, versus abatacept, in patients with rheumatoid arthritis: ATTEST–AMPLE network randomized trial

Robin Daniel Kjersgaard Christensen, Simon Tarp, Daniel E Furst, Lars Erik Kristensen, Henning Bliddal

1 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Efficacy and safety of infliximab or adalimumab, versus abatacept, in patients with rheumatoid arthritis: ATTEST–AMPLE network randomized trial'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab